JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M409523200 on August 31, 2004

J. Biol. Chem., Vol. 279, Issue 45, 46367-46372, November 5, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/45/46367    most recent
M409523200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harry, J. B.
Right arrow Articles by Soldatov, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harry, J. B.
Right arrow Articles by Soldatov, N. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

New Short Splice Variants of the Human Cardiac Cav{beta}2 Subunit

REDEFINING THE MAJOR FUNCTIONAL MOTIFS IMPLEMENTED IN MODULATION OF THE Cav1.2 CHANNEL*

Jo Beth Harry{ddagger}, Evgeny Kobrinsky{ddagger}, Darrell R. Abernethy, and Nikolai M. Soldatov§

From the NIA, National Institutes of Health, Baltimore, Maryland 21224

Received for publication, August 18, 2004


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Two new short splice variants of the Ca2+ channel {beta}2 subunit were cloned from human heart poly(A)(+) mRNA. The 410-amino acid {beta}2f subunit is encoded by exons 1A, 2A, 3, 4, 12, 13, and 14 of the human Cav{beta}2 gene and lacks the protein kinase A phosphorylation site, the {beta}-interaction domain (De Waard, M., Pragnell, M., and Campbell, K. P. (1994) Neuron 13, 495–503), 40% of the {beta}-SH3 domain, and 73% of the guanylate kinase domain of the putative membrane-associated guanylate kinases module (McGee, A. W., Nunziato, D. A., Maltez, J. M., Prehoda, K. E., Pitt, G. S., and Bredt, D. S. (2004) Neuron 42, 89–99), and helix {alpha}3 of the {alpha}1-subunit binding pocket (Van Petegem F., Clark, K. A., Chatelain, F. C., and Minor, D. L., Jr. (2004) Nature 429, 671–675). The {beta}2g transcript has two potential initiation codons. With the second ATG codon, it generates the 164-amino acid {beta}2{Delta}g subunit encoded essentially by the distal part of exon 14, and thus {beta}2{Delta}g completely lacks any of the above motifs. Immunoprecipitation analysis confirmed stable association of {beta}2f and {beta}2{Delta}g with the {alpha}1C subunit. The plasma membrane localization of {beta}2f and {beta}2{Delta}g was substantially increased by co-expression of the {alpha}1C,77 and {alpha}2{delta} subunits. In COS1 cells, {beta}2f and {beta}2{Delta}g increased plasma membrane targeting of the pore-forming {alpha}1C subunit and differentially facilitated ({beta}2f > {beta}2{Delta}g) the voltage gating of otherwise silent Cav1.2 channels. We conclude that it is unlikely that the {beta}-interaction domain, membrane-associated guanylate kinases module, and the {alpha}1-subunit binding pocket helix {alpha}3 are essential for the interaction of the {alpha}1C and {beta}2 subunits and suggest that in addition to the {alpha}1-subunit binding pocket helices {alpha}5 and {alpha}8, a yet unresolved C-terminal {beta}2 region plays a crucial role.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The L-type high voltage-activated Cav1.2 channel is composed of the pore-forming {alpha}1C subunit and the auxiliary {beta} and {alpha}2{delta} subunits. The Cav{beta} subunits (1) are essential cytoplasmic modulators of the Ca2+ channel activity that generate a molecular signal necessary for the facilitation of voltage gating as well as for the correct plasma membrane targeting of the functional Cav1.2 complex (2). The {alpha}1C and {beta} subunits are tightly associated in the channel complex and can be co-immunoprecipitated in mild non-ionic detergents. A conserved {beta}-interaction domain (BID)1 common for genetically different {beta} subunits ({beta}1{beta}4) was proposed as a binding motif interacting with the conserved {alpha}-interaction domain (AID) of the I-II cytoplasmic linker between repeats I and II of an {alpha}1 subunit (3, 4). The {alpha}1-{beta} interaction is believed to chaperon the channel by inhibiting an endoplasmic reticulum retention signal encoded in the {alpha}1 subunit I-II linker (5). Comparative studies showed that {beta} subunits differentially modulate inactivation kinetics (6) and single-channel properties of the Cav1.2 channel (7). We have found that the differential {beta}-subunit modulation predominantly influences the slow inactivation of the channel and is associated with distinct voltage-gated rearrangements between the N-terminal regions of the {alpha}1C and {beta}2 subunits (8). Structural principles underlying the {beta}-subunit modulation of Ca2+ channels were also approached by a search of structural homology with known regulatory proteins. It has been found (9) that the vast central conservative region of {beta}2 subunits shares distant homology with the Src homology 3 (SH3)-guanylate kinase (GK) module of membrane-associated guanylate kinases (MAGUKs). This hypothesis was further elaborated by studying mutations of the rat (N terminus-palmitoylated) {beta}2a subunit that interfere with interactions between SH3 and GK and affect inactivation of Ba2+ currents (10, 11). Intramolecular interactions between the {beta}-subunit SH3 and GK homologues were supported by the results of the recent high-resolution crystallography studies of the {beta}-subunit "cores" of SH3-GK domains alone or in complex with AID (1214). These studies also showed that BID is not available for the binding to AID because it is buried inside the {beta}-subunit structure. Instead, the {alpha}-subunit binding pocket (ABP) distal to the SH3 domain was inferred as a structure engaged in the interaction with AID.

The first cardiac {beta}2 subunits cloned from rat (15) and rabbit (16) hearts have over time been co-identified with five N-terminal splice variants ({beta}2a{beta}2e; for overview, see Ref. 17). A recent comprehensive study revealed that in the human left ventricle there are nine Cav{beta}2 splice variants, including {beta}2b, {beta}2c, {beta}2d, and {beta}2e; the exon 7C isoforms of {beta}2b, {beta}2c, and {beta}2d; the exon 7B isoform of {beta}2b; as well as the {beta}2b transcript lacking exon 7 and truncated in the exon 8 region (18). Here, we report on two new splice variants of the Ca2+ channel {beta}2 subunit gene cloned from the human normal heart poly(A)(+) mRNA and sequentially named {beta}2f and {beta}2g. The {beta}2f and {beta}2g transcripts lack exons encoding a single protein kinase A (PKA) phosphorylation site, BID, as well as a large part ({beta}2f) or the entire SH3-GK module ({beta}2g). Despite the wide structural differences between {beta}2f/{beta}2g and the rest of the {beta}2 subunits, the new {beta}2 subunits yielded fully functional Cav1.2 channels with different inactivation characteristics when co-expressed in COS1 cells with the {alpha}2{delta} and the human vascular {alpha}1C,77 subunits. These data indicate the need to redefine the significance of the previously outlined {beta} subunit functional motifs and implicate the C-terminal region encoded by the distal {beta}2 gene exon in modulation of the channel.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Cloning of the Short Human Cardiac Cav{beta}2 Subunits—The Ca2+ channel {beta}2f and {beta}2g subunits were cloned from the human heart poly(A)(+) mRNA pooled from three Caucasian males (ages 35, 55, and 55; cause of death, trauma) (BD Biosciences Clontech, Palo Alto, CA; catalog number 6533-1) using C. therm. Polymerase One-Step reverse transcriptase (RT)-PCR (Roche Applied Science). The RT reaction was carried out for 30 min at 57 °C with a common RT oligonucleotide primer, 5'-ACATATGATTGCAGTGTAGACC-3', designed from the {beta}2 subunit 3'-untranslated region (nt 804058–804079 in the Human Genome Contig NT_8705.15 of chromosome 10). In the first round of PCR, a common antisense 5'-GCTGTTAGTTATACAAGACTTC-3' primer (nt 804014–804035) was used to amplify {beta}2f and {beta}2g with the sense {beta}2d-specific 5'-ATGGTCCAAAGGGACATGTC-3' (nt 404991–405010) or the {beta}2b-specific 5'-ATGCTTGACAGACGCCTTATA-3' (nt 605181–605201) primer, respectively. PCR mixtures were denatured for 2 min at 94 °C followed by 30 PCR cycles, each composed of denaturing for 45 s at 94 °C, annealing for 1 min at 51 °C, and extension for 2.5 min at 72 °C, with the last step of the last cycle extended to 10 min. For the second round of PCR with "nested primers," a common antisense 5'-gctctagagTCATTGGCGGATGTAAACATC-3' primer (nt 803958–803978, attached to an XbaI linker shown in small letters) was used with the sense 5'-gccaccATGGTCCAAAGGGACATGTCCAAG-3' ({beta}2f) and 5'-gccaccATGCTTGACAGACGCCTTATAGCTC-3' ({beta}2g) primers (incorporating Kozak sequence, shown in small letters in front of the ATG start codon) and the same PCR conditions except with an increased annealing temperature (58 °C). The RT-PCR products were purified using the QIAquick PCR purification kit (Qiagen, Valencia, CA), ligated into the pCR2.1 TA vector (Invitrogen) and sequenced in both directions. To generate {beta}2{Delta}g, the {beta}2g-coding TA clone was amplified using an antisense primer, as shown above for the second round of PCR, and the sense primer 5'-cgggatccgccaccATGTATCTCTGGAGGAGGACCGGG-3', which starts at the second ATG codon and has a Kozak sequence preceded by a BamHI linker at the 5'-end. For expression in eukaryotic cells, the {beta}2f- and {beta}2{Delta}g-coding clones were ligated into the pcDNA3 vector at the XbaI (filled)–NotI and BamHI–XhoI sites, respectively. To systematically investigate subcellular localization of the {alpha}1C and {beta} subunits in situ, their N termini were genetically fused to EYFP and ECFP, respectively. Experimentally, such labeling did not interfere with the functional expression of the channel in our previous (8, 19) and current investigations as compared with the unlabeled subunits. To generate (ECFP)N-{beta}2f, the {beta}2f coding sequence was supplemented with the 5'-NcoI (Klenow-blunted) and 3'-ApaI linkers and ligated into the 5'-ECFP-pcDNA3 vector at the XhoI (filled) and ApaI sites. To generate (ECFP)N-{beta}2{Delta}g, the {beta}2{Delta}g-coding sequence was supplemented with the 5'-BamHI and 3'-XhoI linkers and ligated into the 5'-ECFP-pcDNA3 vector at the respective sites.

Immunoprecipitation Analysis—The (ECFP)N-labeled {beta}2f or {beta}2{Delta}g subunits (replaced by EGFP in the negative control) were expressed in HEK293 cells in the presence or in the absence of {alpha}1C,77 and {alpha}2{delta}. The labeled proteins were co-immunoprecipitated with Living Color full-length A.V. polyclonal antibody (BD Biosciences Clontech) as described in detail earlier (8). The (ECFP)N-labeled {beta} subunits were identified on Western blots by Living Color monoclonal antibody JL-8 (1:8,000 dilution; BD Biosciences Clontech). The co-precipitated {alpha}1C subunits were detected with the affinity-purified rabbit anti-{alpha}1C calcium channel polyclonal antibody (1:10,000; Chemicon International) using an ECL Plus Western blotting detection system (Amersham Pharmacia Biotech).

Electrophysiology—Expression in COS1 cells, all electrophysiological measurements, and fluorescence microscopy were carried out under standard conditions described in Kobrinsky et al. (8) and thus allow for direct comparison with our previous investigations of the {beta}1a and {beta}2 subunits. Briefly, COS1 cells were plated on poly-D-lysine-coated coverslips (MatTek) in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and transfected with cDNAs coding for the {alpha}1C, {beta}, and {alpha}2{delta} subunits (1:1:1, weight for weight) using the Effectene kit (Qiagen). Membrane currents in transfected COS1 cells were recorded 48–72 h after transfection by the patch clamp technique in the whole-cell configuration from individual single cells. The extracellular (bath) solution contained (in mM) 100 NaCl, 20 BaCl2 or CaCl2, 1 MgCl2, 10 glucose, and 10 HEPES at pH 7.4. The internal (pipette) solution contained (in mM) 110 CsCl, 5 MgATP, 10 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetate, 20 tetraethylammonium, 0.2 cAMP, and 20 HEPES at pH 7.4. When filled with the internal solution, pipettes (Kimax-51, Kimble, Vineland, NJ) had resistance ranging between 3 and 6 megohms. Current tracings were low pass-filtered at 1 kHz and sampled at 2.5–5 kHz. Data were acquired using the Axopatch 200B amplifier and pClamp 8.1 software (Axon Instruments, Union City, CA) and corrected for leakage using an on-line P/4 subtraction paradigm.

Fluorescent Microscopy—All cell images were obtained on an epifluorescent Nikon microscope TE200 equipped with a 10-bit digital Hamamatsu CCD camera C4742–95 (Hamamatsu, Bridgewater, NJ). Image processing and analysis were performed with the SimplePCI 5.3 software (Compix, Pittsburgh, PA).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Molecular Cloning and Structural Properties of the Short Human Cardiac {beta}2f and {beta}2g Subunits—Two new short splice variants of the Ca2+ channel {beta}2 subunit gene, named {beta}2f and {beta}2g (Fig. 1A), were cloned by RT-PCR from the poly(A)(+) fraction of the human normal heart mRNA. The RT and PCR primers for the cloning were deduced from the Human Genome Project draft sequence NT_008705 [GenBank] .15 of chromosome 10. The {beta}2f subunit has a theoretical molecular mass of 45.8 kDa, is composed of 410 aa, and has the N terminus encoded by exons 1A and 2A analogous to {beta}2d (18). However, missing in the {beta}2f transcript are exons 5–11 coding for the 250-aa central region of the {beta}2 protein, including BID, as well as 55 of 136 aa (i.e. 40%) of the C-terminal part of the SH3 domain and 192 of 262 aa (i.e. 73%) of the N-terminal part of GK domain. Overall, the following crystallographically resolved structures (13) are absent from the {beta}2f protein: antiparallel {beta}-strands {beta}3–{beta}5 and the second {alpha}-helix ({alpha}2) of the first conserved domain, the entire variable domain V2, as well as parallel {beta}-sheets {beta}6–{beta}9, two {alpha}-helices ({alpha}3–{alpha}4), and two 310 helices ({eta}2-{eta}3) of the second conserved domain. Thus, the entire linker between SH3 and GK ("HOOK domain") present in MAGUKs is deleted from the {beta}2f subunit.



View larger version (27K):
[in this window]
[in a new window]
 
FIG. 1.
Cloning and co-immunoprecipitation analysis of the {beta}2f and {beta}2g subunits. A, a schematic map of the human cardiac {beta}2 subunit transcripts including all exons. The {beta}2f and {beta}2g transcripts are compared with {beta}2d. Exons (boxed) are numbered according to Foell et al. (18), and their size (in base pairs) is shown below each exon. ATG and TGA above the arrows indicate initiation and termination codons, respectively. An approximate position of BID (bold horizontal line) and SH3 and GK motifs (lines with double arrowhead) is illustrated above the {beta}2d transcript. The spliced-out exons in the {beta}2f and {beta}2g transcripts and their parts in exons 3 and 14 of the {beta}2g transcript are shown as gray boxes (unnumbered). Note that the {beta}2g transcript is initiated from exon 2c similar to {beta}2b. Because the reading frame of the {beta}2g transcript opened at the first initiation codon is interrupted at the position 153, the second ATG (shown above exon 3) at the position 98 was utilized to generate the {beta}2{Delta}g transcript. B, co-immunoprecipitation with the short {beta} splice variants. The (ECFP)N-{beta}2f(1), (ECFP)N-{beta}2{Delta}g (2) or no {beta} subunit (3,4) was co-expressed in HEK293 cells with (1–3) or without 4) the {alpha}1C,77 and {alpha}2{delta} subunits. EGFP was co-expressed in control sample 3. Cells were lysed by freeze-thaw. To remove free {beta} subunits and other cytosolic proteins, the crude membrane particulate fractions were prepared from the lysed cells as described earlier (8). Membranes were solubilized with 0.5% Nonidet P-40, and the channel proteins were immunoprecipitated with the antibody against green fluorescent protein, separated by SDS-polyacrylamide gel electrophoresis, and analyzed by immunoblotting. The (ECFP)N-labeled {beta}2 splice variants (1,2) and EGFP (3) were detected on the blot by the monoclonal antibody against green fluorescent protein, whereas the co-immunoprecipitated {alpha}1C subunit was detected using the anti-{alpha}1C antibody.

 
The even smaller {beta}2g-subunit transcript is composed of exon 2c followed by the 72-nt upstream portion of exon 3 and the 463-nt distal part of exon 14. Although exon 2c encodes the N terminus of the {beta}2b subunit, the reading frame is interrupted just 150 nt downstream of the first initiation codon. The second ATG codon occurs 91 nt downstream from the first one, or 34 nt downstream from the acceptor splice site of exon 3. Its reading frame includes the distal 463-nt sequence of the {beta}2 3'-terminal exon 14. Thus, both exons 3 and 14 are alternatively spliced in {beta}2g, but the respective utilized donor and acceptor splice sites do not conform to the consensus sequences. With the second initiation codon, the {beta}2g-subunit transcript encodes a 164-aa protein with the calculated molecular mass of 19.5 kDa. This splice variant, referred further as {beta}2{Delta}g, has been generated by a PCR deletion of the 91-nt upstream region including the first ATG codon. Both the {beta}2f and {beta}2{Delta}g subunits lack the PKA phosphorylation site (RKST in position 216 of the human {beta}2d) that was shown to be involved in the PKA-mediated stimulation of cardiac L-type Ca2+ currents (20). In addition, {beta}2f retains only 6 of 12 potential protein kinase C phosphorylation sites, (S/T)X(R/K), in positions 78, 198, 302, 343, 382, and 441. The last three sites are also present in the {beta}2{Delta}g subunit.

Although {beta}2f and {beta}2{Delta}g were cloned from the polyadenylated fraction of mRNA, none of the studied short {beta}2 splice variants has yet been shown to be expressed in the human heart as functional proteins. Because of this and as the usage of initiation codons in {beta}2g remains unknown, {beta}2{Delta}g is considered a putative splice variant of the {beta}2g subunit. Nevertheless, because {beta}2{Delta}g lacks not only BID and the entire SH3-GK domains but also the variable {beta}2-subunit N termini-coding exons, {beta}2{Delta}g is particularly interesting for the study of the functional significance of these genetically deleted motifs. To investigate whether the structural deletions discovered in the new {beta}2 splice variants affect their interaction with the {alpha}1C subunits, co-immunoprecipitation of the short {beta}2 subunits with the wild-type {alpha}1C,77 was analyzed by Western blot assay (Fig. 1B). ECFP was genetically fused to the N termini of the new {beta}2 splice variants by in-frame ligation of the ECFP and {beta}2f/{beta}2{Delta}g coding sequences, and the (ECFP)N-labeled {beta}2 subunits were co-expressed in HEK293 cells with the {alpha}2{delta} and {alpha}1C,77 subunits. Similar to the {beta}1a and the {beta}2(r) subunits (8), the (ECFP)N labeling did not compromise their functional activity (data not shown). Use of antibody against GFP to co-immunoprecipitate (ECFP)N-{beta}2 variants and {alpha}1C,77 from the solubilized membrane particulate fraction of HEK293 cells helped to avoid a contamination with the nonassociated cytosolic (ECFP)N-{beta}2 and the membrane-bound orphan {alpha}1C subunits. Both {beta}2f (Fig. 1B, lane 1) and {beta}2{Delta}g (lane 2) pulled down the {alpha}1C,77 protein from the solubilized membrane preparations suggesting stable association between the subunits. A similar observation was made with {beta}1a, {beta}2(r) (8), and other {beta} proteins. In controls, no immunoprecipitation of the {alpha}1C subunit by anti-GFP antibody was found in the absence of (ECFP)N-{beta}2 variants in COS1 cell with (Fig. 1B, lane 3) or without (lane 4) EGFP co-expressed. These data indicate that the {alpha}2{delta} and {alpha}1C subunits are necessary for the plasma membrane targeting by the {beta}2f and {beta}2{Delta}g subunits.

The {beta}2f Subunit Stimulates the Plasma Membrane Targeting and Facilitates the Cav1.2 Channel Voltage Gating—To better characterize the cellular location of the expressed {alpha}1C and {beta} subunits, the (ECFP)N-labeled {beta}2f and {beta}2{Delta}g were expressed with {alpha}1C,77 and {alpha}2{delta} subunits in COS1 cells lacking the endogenous Ca2+ channels (21). In contrast to the data obtained with Xenopus oocytes (10, 14) and HEK293 cells (11), heterologous expression of the {alpha}1C and {alpha}2{delta} subunits in COS1 cells did not induce an appreciable Ca2+ channel activity (Fig. 2A) unless a {beta} subunit was co-expressed (Fig. 2B). Thus, selection of the COS1 cells expression system allowed us to avoid ambiguity in the assessment of the {beta}-subunit modulation of the Ca2+ channel typical for the cited studies (10, 11, 14) and to define the {beta}-subunit modulation here as a facilitation of the Ca2+ channel voltage gating by a {beta} subunit. Essential prerequisites for a {beta}-subunit modulation of the channel are binding of Cav{beta} to the {alpha}1C subunit and targeting of the oligomeric channel complex to the plasma membrane.



View larger version (55K):
[in this window]
[in a new window]
 
FIG. 2.
Effect of the {beta}2f subunit on functional expression, subcellular distribution, and electrophysiological properties of the Ca2+ channel. A, IBa recorded from a COS1 cell transfected by the (EYFP)N-{alpha}1C,77 and {alpha}2{delta} subunits (inset shows the whole-cell EYFP) in response to a 600-ms test pulse to +20 mV from the holding potential of –90 mV. B, panel a, representative traces of IBa in response to the indicated test pulses (Vh = –90 mV) from a COS1 cell transiently transfected with the (EYFP)N-{alpha}1C,77, {alpha}2{delta} and {beta}2f subunits. Panel b, phase-contrast cell image with a shadow of patch pipette; panel c, whole-cell EYFP fluorescence. Panel d, average normalized I-V relationship (n = 9) for IBa through the (EYFP)N-{alpha}1C,77/{alpha}2{delta}/{beta}2f channel. C, whole-cell fluorescence from COS1 cells expressing the (EYFP)N-{alpha}1C,77 and {alpha}2{delta} subunits in the absence (a) or in the presence (b) of the {beta}2f subunit or from COS1 cells expressing the (ECFP)N-{beta}2f and {alpha}2{delta} subunits in the absence (c) or in the presence (d) of the {alpha}1C,77 subunit. The expression level of the labeled proteins was approximately the same (compare unadjusted fluorescence scales in the right panels). D, representative traces of ICa (a) or IBa (b–d) evoked by a test pulse to +20 mV applied for 0.6 (a, b), 5 (c), or 30 s (d). E, whole-cell fluorescence from COS1 cells expressing the (ECFP)N-{beta}2(r) subunit in the absence (a) or in the presence (b) of the {alpha}1C,77 and {alpha}2{delta} subunits. Control panel c shows surface membrane targeting of (EYFP)N-{alpha}1C,77 co-expressed with the {alpha}2{delta} and {beta}2(r) subunits. Panel d, representative 30-s trace of IBa through the (EYFP)N-{alpha}1C,77/{alpha}2{delta}/{beta}2(r) channel (8). Vh = –90 mV. Dashed lines show a zero current. Scaling bars, 3 µm.

 
In the absence of Cav{beta}, the (EYFP)N-labeled {alpha}1C,77 is essentially retained in intracellular compartments of the cell (Fig. 2C, a). Similar to {beta}2(r) (Fig. 2E, c) (8), co-expression of the {beta}2f subunit increased surface membrane targeting of (EYFP)N-{alpha}1C,77, which is evident from a comparison of the subcellular distribution of fluorescence in the absence (Fig. 2C, a) and in the presence of {beta}2f (Fig. 2C, b). Conversely, {alpha}1C increased plasma membrane targeting of the {beta}2f subunit. In the absence of {alpha}1C, the (ECFP)N-labeled {beta}2f subunit was diffusely distributed over the cytoplasm (Fig. 2C, c). A similar intracellular localization, typical for cytosolic proteins, was observed with the full-size (ECFP)N-{beta}2(r) (Fig. 2E, a). Co-expression of {alpha}1C,77 increased the plasma membrane localization of the (ECFP)N-{beta}2f subunit (Fig. 2C, d) analogously to the effect of {alpha}1C,77 on the (ECFP)N-{beta}2(r) in positive control (Fig. 2E, b). These data corroborate the results of immunoprecipitation analysis (Fig. 1B, lane 1) and provide strong evidence that {beta}2f binds to {alpha}1C,77 and facilitates the channel formation and its plasma membrane targeting. Thus, the {beta}2f subunit displayed both the chaperon function and binding to {alpha}1C, which are features characteristic for {beta}2(r) and other {beta} subunits (2).

Despite the large structural differences between {beta}2f and the other known {beta}2 subunits, when co-expressed in COS1 cells with the human vascular {alpha}1C,77 subunit and {alpha}2{delta}, the new {beta}2f subunit yields a fully functional Cav1.2 channel. Fig. 2B (panel c) shows representative traces of the Ba2+ current (IBa) evoked by the 600-ms test pulses to the indicated voltages applied from Vh = –90 mV. The corresponding averaged normalized I-V relationship is presented in Fig. 2B, d. The values for the half-maximal activation (V0.5 = 1.8 ± 1.7 mV) and the slope factor (kI-V = –7.9 ± 0.9; n = 9) were essentially similar to those reported earlier for IBa through the {alpha}1C,77/{alpha}2{delta}/{beta}2(r) channel expressed in Xenopus oocytes (22). Respectively, a replacement of Ba2+ for Ca2+ as the charge carrier (Fig. 2D, a) produced a typical strong acceleration of the current decay characteristic for Ca2+-induced inactivation of the Cav1.2 channel. Contrasting with the rabbit {beta}2(r) subunit, the new short {beta}2f renders notably faster inactivation of IBa. Fig. 2D (b–d) shows maximum IBa elicited by test pulses of different durations to +20 mV. A two-exponential fitting of the 30-s IBa through the (EYFP)N-{alpha}1C,77/{alpha}2{delta}/{beta}2f channel (n = 5) showed the inactivation time constants ({tau}) and fractions (I) of the fast and slow components to be {tau}f = 465 ± 20 ms (If = 46.4 ± 1.4%) and {tau}s = 4.31 ± 0.68 s (Is = 35.2 ± 2.1%), respectively. Although complete inactivation of the current was not reached even with the 45-s pulse, the fraction of the current that remains by the end of the 30-s pulse (18.0 ± 2.0%) was, on average, significantly (p < 0.05) smaller that those we have found (27.5 ± 3.3%) with the {beta}2(r) subunit. The fast component of IBa through the (EYFP)N-{alpha}1C,77/{alpha}2{delta}/{beta}2(r) channel (Fig. 2E, d) ({tau}f = 499 ± 68 ms; If = 53.4 ± 1.6%; n = 5) was essentially similar to those of the {beta}2f channel current. However, the slow component showed a delayed decay ({tau}s = 12.88 ± 2.40 s; Is = 19.4 ± 4.7%; p < 0.01). Overall, our study revealed that {beta}2f exhibits properties characteristic of the {beta}2 subunits and yields a fully functional Cav1.2 channel. These data suggest that a requirement of the {beta} subunit for functional conformation of the channel (6, 23) is conserved in the regions of {beta}2 other than BID and the missing essential parts of SH3-GK.

The {beta}2{Delta}g Subunit Narrows the Functional Correlates of the {beta} Subunit to the C-terminal 153-Amino Acid Region—The immunoprecipitation analysis (Fig. 1B, lane 2) showed that the {beta}2{Delta}g subunit binds to {alpha}1C,77 despite the lack of BID, the entire MAGUK module, and the ABP. The {beta}2{Delta}g subunit is composed of 164 aa of which the N-terminal 11 residues are new to {beta}2 subunits. The last 153 aa are common for the C-terminal region of {beta}2 subunits encoded by the distal part of exon 14. Our data indicate that this C-terminal region is sufficient to confer the assembly of the functional channel. Fig. 3 shows cellular distribution and functional expression of the Ca2+ channel assembled with {beta}2{Delta}g. When co-expressed with {alpha}2{delta} but in the absence of {alpha}1C, the (ECFP)N-{beta}2{Delta}g subunit was diffusely distributed over the cytoplasm without selectively targeting the plasma membrane (Fig. 3A, a). The {alpha}1C,77 subunit strongly enhanced accumulation of (ECFP)N-{beta}2{Delta}g in the plasma membrane (Fig. 3A, panel b). Conversely, {beta}2{Delta}g effectively increased membrane targeting of the (EYFP)N-labeled {alpha}1C,77 (Fig. 3A, compare c and d). Thus, {beta}2{Delta}g retains the molecular signals necessary for binding to the {alpha}1C subunit and plasma membrane targeting of the channel.



View larger version (53K):
[in this window]
[in a new window]
 
FIG. 3.
Cellular distribution and functional expression of the Ca2+ channel directed by {beta}2{Delta}g in COS1 cells. A, comparison of whole-cell fluorescence from COS1 cells expressing the (ECFP)N-{beta}2{Delta}g and {alpha}2{delta} subunits in the absence (a) or in the presence (b) of the {alpha}1C,77 subunit or from COS1 cells expressing the (EYFP)N-{alpha}1C,77 and {alpha}2{delta} subunits in the absence (c) or in the presence (d) of the {beta}2{Delta}g subunit. Right panels show fluorescence scales. B, representative traces of ICa (left) and IBa (right) through the (EYFP)N-{alpha}1C,77/{alpha}2{delta}/{beta}2{Delta}g channel evoked by 600-ms test pulses to +20 mV from Vh = –90 mV. C, representative 30-s trace of IBa recorded under the same voltage protocol. Dashed line shows zero current. Scaling bars, 3 µm.

 
Co-expression of the {alpha}1C,77, {alpha}2{delta}, and {beta}2{Delta}g subunits gave rise to a functional Ca2+ channel that exhibited somewhat unusual properties. First, with both Ca2+ and Ba2+ as the charge carrier, the maximum amplitude of the current was ~10 times smaller than through the {alpha}1C,77/{alpha}2{delta}/{beta}2f channel. Fig. 3B shows the 600-ms traces of the Ca2+ and Ba2+ currents through the {beta}2{Delta}g channel evoked by depolarization to +20 mV from Vh = –90 mV. Both the activation and inactivation properties of the {beta}2{Delta}g channel are significantly different from those of the {beta}2f channel. The Ca2+ current did not show accelerated inactivation (Fig. 3B, left trace), which would be characteristic for the Ca2+-conducting L-type channels (e.g. compare traces a and b in Fig. 2D), thus suggesting that Ca2+-induced inactivation may be impaired by the {beta}2{Delta}g subunit. The activation of the Ba2+ current is delayed for ≥1 s (Fig. 3, B and C). A two-exponential fitting of inactivation kinetics of the 30-s IBa through the (EYFP)N-{alpha}1C,77/{alpha}2{delta}/{beta}2{Delta}g channel (n = 6) showed a substantial decrease of the fast component ({tau}f = 350 ± 150 ms; If = 16.5 ± 4.0%), a prolongation of the slow decay ({tau}s = 13.9 ± 5.3 s; Is = 47.5 ± 3.0%), and an almost 2-fold increase of the sustained current component by the end of the 30-s pulse (36.0 ± 5.5%). Thus, the {beta}2{Delta}g and {beta}2f channels clearly exhibit differential modulation of inactivation despite the lack of MAGUK and BID structures. Overall, {beta}2{Delta}g demonstrates typical properties of the Ca2+ channel {beta} subunits, including binding to the {alpha}1C subunit and stimulation of the surface membrane targeting by the channel, but provides an altered and weak facilitation of channel gating.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The most interesting result of this study is that vast deletions in the central region of the {beta}2 subunit that include most of or the entire SH3-GK region do not compromise the {beta}-subunit modulation of the Ca2+ channel. The {beta}2f subunit exhibits an array of properties that resemble those of the {beta}2(r) and other {beta}2 subunits, whereas the shortest known {beta}2{Delta}g isoform shows more unusual features in modulation of the channel. Our results with the {beta}2f subunit confirm the main structural implications of the crystallographic study of the Cav{beta}2a-AID complex (1214) by highlighting the fact that it is the C-terminal region encoded by exons 12–14 that appears to bear essential structures involved in interaction with an {alpha}1 subunit. Although it is not clear to what extent the identified structural features of the {beta}2"conserved core"are preserved in its remnants in the {beta}2f subunit, they may include the C-terminal fragment of the helix {alpha}5 (153–159) and the entire helix {alpha}8 (196–215) that jointly form a part of ABP (13). However, {beta}2f lacks the helix {alpha}3 co-identified with the ABP. It is unlikely that the small parts of the SH3 and GK domains remaining in the {beta}2f subunit are sufficient to support their cross-interaction, because the distal loop and strand E of the conserved domain I implemented in this interaction (12) are both absent from {beta}2f.

The remnant of the first conserved domain of {beta}2f, encoded in part by exons 3 and 4 (aa 73–152), shows 72–80% homology with the other cloned human {beta} subunits, including {beta}1B-1 and {beta}1B-2 (24), {beta}3 (25), and {beta}4 (26). The remnant sequence (aa 153–217) of the second conserved region of {beta}2f, which includes helices {alpha}5 and {alpha}8 of the ABP encoded in part by exons 12 and 13, shares 83–88% of the overall homology with other {beta} subunits. Experimentally established conventional modulation of the channel by the {beta}2f subunit suggests that the combination of {alpha}5 and {alpha}8 helices is an important structural requirement for ABP and/or that helix {alpha}3 might be replaced in ABP by an unidentified motif(s) in {beta}2f. In contrast, {beta}2{Delta}g lacks any structural bases for ABP or MAGUK, and {beta}2{Delta}g does not share a substantial (>30%) homology with the {beta}1, {beta}3, and {beta}4 subunits. Nevertheless, {beta}2{Delta}g binds to the {alpha}1C,77 subunit (Fig. 1B, lane 2), stimulates membrane targeting of the channel (Fig. 3), and shows properties of a weak modulator of the Cav1.2 channel voltage gating. Specifically, {beta}2{Delta}g supports slowly inactivating Ba2+ currents at prolonged depolarization, which is a characteristic feature of other {beta}2 subunits. There are no structural data available for the {beta}2-subunit C-terminal region to explain the results of the functional evaluation of the {beta}2{Delta}g except to suggest that within the C-terminal 153-amino acid sequence, an essential structure of the {beta}2 subunit is present that endows a modulation of the channel via functional interaction with {alpha}1C.

The {beta} subunit is an important component of a molecular complex that determines cytoplasmic helical packing stabilizing channel gating. We hypothesize that it is the Cav{beta}2 N-terminal half that finely tunes the gating facilitation and affects differential modulation of the Ca2+ channel current inactivation and the voltage-gated rearrangements of the {alpha}1C and {beta} subunit N-tails (8). The MAGUK module may contribute to this regulation, but its partial or even complete deletion does not impede the channel modulation as defined in this paper.

Several Cav{beta} variants with truncated C-terminals were previously identified (18). Our work has established the fact that the main splice isoforms ({beta}2a{beta}2e) of the {beta}2 subunit gene may generate smaller functional variants through the genetically encoded deletions of the central regions. These data interject significant complications in the reassessment of tissue and cellular distribution of Cav{beta}2 variants. Development of specific immunohistochemical tools for {beta}2f and {beta}2g is problematic because they share the same aa sequences with other {beta}2 subunits. Given the large size of untranslated regions of the {beta}2-subunit transcripts (15), relatively small structural deletions encoded in {beta}2f and {beta}2g may be difficult to assess by Northern blot analysis.

Our results also show that alternative splicing of the {beta}2 subunit gene may affect regulation of the Cav1.2 channels in the human heart by PKA. Activation of PKA through the {beta}-adrenergic receptor pathway is crucial for an up-regulation of the cardiac L-type Ca2+ currents (27). This effect was found to be in part because of PKA phosphorylation of a single specific site of the {beta}2 subunit (20). Because this site is genetically deleted from the naturally occurring short splice variants of the human {beta}2 subunit described in this paper, these variants may have a distinct role (or no role) in human cardiac electrophysiology. In any case, the discovery of the new functional short {beta}2-subunit isoforms lacking many of the predicted functional motifs adds understanding to the molecular bases for the {beta}-subunit modulation of Ca2+ channels and may give rise to new molecular tools of the study of mechanisms of Ca2+ signal transduction.


    FOOTNOTES
 
* This work was supported by the Intramural Research Program, NIA, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY675091 [GenBank] ({beta}2f) and AY675092 [GenBank] ({beta}2g). Back

{ddagger} Both authors contributed equally to this work. Back

§ To whom correspondence should be addressed. Tel.: 410-558-8343; Fax: 410-558-8318; E-mail: soldatovN{at}grc.nia.nih.gov.

1 The abbreviations used are: BID, {beta}-interaction domain; AID, {alpha}-interaction domain; SH3, Src homology 3; GK, guanylate kinase domain; MAGUK, membrane-associated guanylate kinase; ABP, {alpha}-subunit binding pocket; PKA, protein kinase A; RT, reverse transcriptase; nt, nucleotide(s); EYFP, enhanced yellow fluorescent protein; ECFP, enhanced cyan fluorescent protein; EGFP, enhanced green fluorescent protein; aa, amino acid(s); HEK, human embryonic kidney; GFP, green fluorescent protein; {beta}2(r), rabbit cardiac {beta}2 subunit; Vh, holding potential. Back


    ACKNOWLEDGMENTS
 
We are grateful to Mike Shi for help with electrophysiology and to Sarah Bentil and Yasir Kazmi for help with fluorescent images.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Ruth, P., Rohrkasten, A., Biel, M., Bosse, E., Regulia, S., Meyer, H. E., Flockerzi, V., and Hofmann, F. (1989) Science 245, 1115–1118[Abstract/Free Full Text]
  2. Dolphin, A. C. (2003) J. Bioenerg. Biomembr. 35, 599–620[CrossRef][Medline] [Order article via Infotrieve]
  3. Pragnell, M., De Waard, M., Mori, Y., Tanabe, T., Snutch, T. P., and Campbell, K. P. (1994) Nature 368, 67–70[CrossRef][Medline] [Order article via Infotrieve]
  4. De Waard, M., Pragnell, M., and Campbell, K. P. (1994) Neuron 13, 495–503[CrossRef][Medline] [Order article via Infotrieve]
  5. Bichet, D., Cornet, V., Geib, S., Carlier, E., Volsen, S., Hoshi, T., Mori, Y., and De Waard, M. (2000) Neuron 25, 177–190[CrossRef][Medline] [Order article via Infotrieve]
  6. Lory, P., Varadi, G., Slish, D. F., Varadi, M., and Schwartz, A. (1993) FEBS Lett. 315, 167–172[CrossRef][Medline] [Order article via Infotrieve]
  7. Hullin, R., Khan, I. F. Y., Wirtz, S., Mohacsi, P., Varadi, G., Schwartz, A., and Herzig, S. (2003) J. Biol. Chem. 278, 21623–21630[Abstract/Free Full Text]
  8. Kobrinsky, E., Kepplinger, K. J. F., Yu, A., Harry, J. B., Kahr, H., Romanin, C., Abernethy, D. R., and Soldatov, N. M. (2004) Biophys. J. 87, 844–857[Abstract/Free Full Text]
  9. Hanlon, M. R., Berrow, N. S., Dolphin, A. C., and Wallace, B. A. (1999) FEBS Lett. 445, 366–370[CrossRef][Medline] [Order article via Infotrieve]
  10. McGee, A. W., Nunziato, D. A., Maltez, J. M., Prehoda, K. E., Pitt, G. S., and Bredt, D. S. (2004) Neuron 42, 89–99[CrossRef][Medline] [Order article via Infotrieve]
  11. Takahashi, S. X., Miriyala, J., and Colecraft, H. M. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 7193–7198[Abstract/Free Full Text]
  12. Opatowsky, Y., Chen, C.-C., Campbell, K. P., and Hirsch, J. A. (2004) Neuron 42, 387–399[CrossRef][Medline] [Order article via Infotrieve]
  13. Van Petegem, F., Clark, K. A., Chatelain, F. C., and Minor, D. L., Jr. (2004) Nature 429, 671–675[CrossRef][Medline] [Order article via Infotrieve]
  14. Chen, Y.-H., Li, M.-H., Zhang, Y., He, L.-L., Yamada, Y., Fitzmaurice, A., Shen, Y., Zhang, H., Tong, L., and Yang, J. (2004) Nature 429, 675–680[CrossRef][Medline] [Order article via Infotrieve]
  15. Perez-Reyes, E., Castellano, A., Kim, H. S., Bertrand, P., Baggstrom, E., Lacerda, A. E., Wei, X., and Birnbaumer, L. (1992) J. Biol. Chem. 267, 1792–1797[Abstract/Free Full Text]
  16. Hullin, R., Singer-Lahat, D., Freichel, M., Biel, M., Dascal, N., Hofmann, F., and Flockerzi, V. (1992) EMBO J. 11, 885–890[Medline] [Order article via Infotrieve]
  17. Colecraft, H. M., Alseikhan, B., Takahashi, S. X., Chaudhuri, D., Mittman, S., Yegnasubramanian, V., Alvania, R. S., Johns, D. C., Marban, E., and Yue, D. T. (2002) J. Physiol. (Lond.) 541, 435–452[Abstract/Free Full Text]
  18. Foell, J. D., Balijepalli, R. C., Delisle, B. P., Yunker, A. M. R., Robia, S. L., Walker, J. W., McEnery, M. W., January, C. T., and Kamp, T. J. (2004) Physiol. Genomics 17, 183–200[Abstract/Free Full Text]
  19. Kobrinsky, E., Schwartz, E., Abernethy, D. R., and Soldatov, N. M. (2003) J. Biol. Chem. 278, 5021–5028[Abstract/Free Full Text]
  20. Bünemann, M., Gerhardstein, B. L., Gao, T., and Hosey, M. M. (1999) J. Biol. Chem. 274, 33851–33854[Abstract/Free Full Text]
  21. Meir, A., Bell, D. C., Stephens, G. J., Page, K. M., and Dolphin, A. C. (2000) Biophys. J. 79, 731–746[Abstract/Free Full Text]
  22. Soldatov, N. M., Zühlke, R. D., Bouron, A., and Reuter, H. (1997) J. Biol. Chem. 272, 3560–3566[Abstract/Free Full Text]
  23. Nishimura, S., Takeshima, H., Hofmann, F., Flockerzi, V., and Imoto, K. (1993) FEBS Lett. 324, 283–286[CrossRef][Medline] [Order article via Infotrieve]
  24. Powers, P. A., Liu, S., Hogan, K., and Gregg, R. G. (1992) J. Biol. Chem. 267, 22967–22972[Abstract/Free Full Text]
  25. Murakami, M., Wissenbach, U., and Flockerzi, V. (1996) Eur. J. Biochem. 236, 138–143[Medline] [Order article via Infotrieve]
  26. Taviaux, S., Williams, M. E., Harpold, M. M., Nargeot, J., and Lory, P. (1997) Hum. Genet. 100, 151–154[Medline] [Order article via Infotrieve]
  27. McDonald, T. F., Pelzer, S., Trautwein, W., and Pelzer, D. J. (1994) Physiol. Rev. 74, 365–507[Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Q. Z. Lao, E. Kobrinsky, J. B. Harry, A. Ravindran, and N. M. Soldatov
New Determinant for the CaV{beta}2 Subunit Modulation of the CaV1.2 Calcium Channel
J. Biol. Chem., June 6, 2008; 283(23): 15577 - 15588.
[Abstract] [Full Text]